Lv1
10 积分 2023-11-10 加入
Clinical Significance of HHLA2 as a Novel Therapeutic Target for Colorectal Cancer
2个月前
已完结
SARM1 in the pathogenesis of immune-related disease
3个月前
已完结
Clinical Pharmacology Characterization and Dose Selection of Xaluritamig, a Next Generation XmAb® 2+1 T‐Cell Engager, in Prostate Cancer Patients
3个月前
已完结
Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancer
4个月前
已完结
Accelerated Formulation Development of Monoclonal Antibodies (mAbs) and mAb-Based Modalities: Review of Methods and Tools
4个月前
已完结
A Mechanistic Physiologically‐Based Pharmacokinetic Platform Model to Guide Adult and Pediatric Intravenous and Subcutaneous Dosing for Bispecific T Cell Engagers
4个月前
已完结
Targeting mitophagy in neurodegenerative diseases
4个月前
已完结
Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches
4个月前
已完结
Cell-Penetrating Peptides-Mediated Therapeutic Agents Delivery into the Central Nervous System
5个月前
已完结
Nanobody-based bispecific antibody engagers targeting CTLA-4 or PD-L1 for cancer immunotherapy
5个月前
已完结
皖公网安备34019202002308
